Form 4 for CYH COMMUNITY HEALTH SYSTEMS INC
Accepted 2025-03-03 00:00:00 ET · period of report 2025-03-01 · accession 0000950170-25-031109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-03-01 | CYH | SMITH WAYNE T | Dir | M - OptEx | $0.00 | +30.2K | 5.24M | +0.6% | $0 |
| D | 2025-03-03 | 2025-03-01 | CYH | SMITH WAYNE T | Dir | M - OptEx | $0.00 | -30.2K | 149.8K | -17% | $0 |
| D | 2025-03-03 | 2025-03-01 | CYH | SMITH WAYNE T | Dir | D - Sale to Iss | $0.00 | -149.8K | 0 | -100% | $0 |
| D | 2025-03-03 | 2025-03-01 | CYH | SMITH WAYNE T | Dir | A - Grant | $0.00 | +59.8K | 287.2K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | M | A | 30,240 | $0.00 | 5,236,979 | D | — | — | (F1) The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 16.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (30,240), and the remaining 83.2% of the target number has been forfeited (149,760). |
| 2 | Derivative | Performance Based Restricted | 2025-03-01 | M | D | 30,240 | $0.00 | 149,760 | D | $0.00 · — to — | 30,240 Common Stock | (F1) The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 16.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (30,240), and the remaining 83.2% of the target number has been forfeited (149,760). |
| 3 | Derivative | Performance Based Restricted | 2025-03-01 | D | D | 149,760 | $0.00 | 0 | D | $0.00 · — to — | 149,760 Common Stock | (F1) The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 16.8% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (30,240), and the remaining 83.2% of the target number has been forfeited (149,760). |
| 4 | Derivative | Restricted Stock Units | 2025-03-01 | A | A | 59,801 | $0.00 | 287,210 | D | $0.00 · — to — | 59,801 Common Stock | (F2) These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. |